Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-05-06The Utility and Relevance of Exome Sequence Analysis and Circulating Tumour DNA in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2019-05-06Skin Cancer Screening Education Study
-
CLINICAL_TRIALS study record update · 2019-05-0618FluoroDeoxyGlucose-Positron Emission Tomography (PET) in Patients With Melanoma or Non Small Cell Lung Cancer Treated With Immunotherapy
-
CLINICAL_TRIALS study record update · 2019-04-23Phase IIIb/IV, Randomized, Double Blinded, Study of Nivolumab 3 mg/kg in Combination With Ipilimumab 1 mg/kg vs Nivolumab 1 mg/kg in Combination With Ipilimumab 3 mg/kg in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2019-04-16CONTACT: A Prospective Interventional Multicentre Before-after Study for the Implementation of a Care Pathway to Increase Self-management of Patients With Cancer Who Are Treated With Oral Anticancer Medications
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-04-02Patients Diagnosed With Advanced Malignancy or Myelodysplasia, Tested by Standardized Sequencing, and Treated by Physician-Determined Care Plan: A CureOne Observational Registry (N1)
-
CLINICAL_TRIALS study record update · 2019-03-21A Phase Ib Study of Pembrolizumab (MK-3475) in Chinese Subjects With Locally Advanced or Metastatic Melanoma (Keynote-151)
-
CLINICAL_TRIALS study record update · 2019-03-19GSK 2132231A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Resected Melanoma
-
CLINICAL_TRIALS study record update · 2019-03-07Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma
-
CLINICAL_TRIALS study record update · 2019-03-06Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
-
CLINICAL_TRIALS study record update · 2019-02-21Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration
-
CLINICAL_TRIALS study record update · 2019-02-18Phase II Biomarker Study Evaluating The Upfront Combination Of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus The Combination After Eight Weeks Of Monotherapy With Dabrafenib Or Trametinib In Patients With Metastatic And Unresectable Stage III Or IV Melanoma Harbouring An Activating BRAF Mutation
-
CLINICAL_TRIALS study record update · 2019-02-15An Open-Label, Multicenter Dose-Escalation Study to Evaluate the Safety and Tolerability of AP 12009 (Trabedersen), Administered Intravenously in Patients With Advanced Tumors Known to Overproduce TGF-β2.
-
CLINICAL_TRIALS study record update · 2019-02-08PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
-
CLINICAL_TRIALS study record update · 2019-02-08Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
-
CLINICAL_TRIALS study record update · 2019-01-30A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2019-01-30An Observational Study to Evaluate the Effectiveness and Safety of Ipilimumab, Administered During the European Expanded Access Programme in Pretreated Patients With Advanced (Unresectable or Metastatic) Melanoma
-
CLINICAL_TRIALS study record update · 2019-01-30ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
-
CLINICAL_TRIALS study record update · 2019-01-22Survival in Adult Patients With BRAF V600 Mutation-Positive Advanced Melanoma: A Non-Interventional Ambispective Study of a Cohort of Patients Treated With Cobimetinib During the French Early Access Program (TAU)
-
CLINICAL_TRIALS study record update · 2019-01-10Phase III Open Label Trial for Use of [18F]-Fluoro-Deoxy-Glucose (18F-FDG) in Positron Emission Tomography Imaging in Oncology
-
CLINICAL_TRIALS study record update · 2019-01-10SAbR-Induced Innate Immunity in Urothelial Carcinoma, Melanoma, and Cervical Carcinoma
-
CLINICAL_TRIALS study record update · 2019-01-08Expansion ex Vivo Des Cellules Tumorales Circulantes Comme modèle de Pharmacologie prédictive Des Cancers. EXPEVIVO-CTC
-
CLINICAL_TRIALS study record update · 2019-01-08Phase IIIb, Randomized, Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Previously Untreated Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2019-01-04Adjuvant Immunotherapy With Anti-PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-risk Stage III Melanoma: A Randomized, Double- Blind Phase 3 Trial of the EORTC Melanoma Group
-
CLINICAL_TRIALS study record update · 2019-01-04Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated Light